Prostate specific antigen density of the transition zone for early detection of prostate cancer

Journal of Urology

Volumn 160, Issue 2, 1998, Pages 411-418

  Djavan, B ^a   Zlotta, A R ^a   Byttebier, G ^a   Shariat, S ^a   Omar, M ^a   Schulman, C C ^a   Marberger, M ^a  

^a NONE

Author keywords

Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; ECHOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECEIVER OPERATING CHARACTERISTIC;

EID: 0032323222     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62911-2     Document Type: Article

References (30)

1. Parker, S. L., Tong, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1996. CA, 46: 5, 1996.
2. Dijkman, G. A. and Debruyne, F. M.: Epidemiology of prostate cancer. Eur. Urol., 30: 281, 1996.
3. Brawer, M. K.: Prostate-specific antigen: critical issues. Urology, 44: 9, 1994.
4. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
5. Morote, J., Raventós, C. X., Lorente, J. A., Lopez-Pacios, M. A., Encabo, G., de Torres, I. and Andreu, J.: Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml. J. Urol., 158: 502, 1997.
6. Vashi, A. R., Wojno, K. J., Henricks, W., England, B. A., Vessella, R. L., Lange, P. H., Wright, G. L., Jr., Schellhammer, P. F., Weigand, R. A., Olson, R. M., Dowell, B. L., Borden, K. K. and Oesterling, J. E.: Determination of the "reflex range" and appropriate outpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system. Urology, 49: 19, 1997.
7. Bangma, C. H., Rietbergen, J. B. W., Kranse, R., Blijenberg, B. G., Petterson, K. and Schröder, F. H.: The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. J. Urol., 157: 2191, 1997.
8. Bedushi, M. C. and Oesterling, J. E.: Prostate-specific antigen density. Urol. Clin. N. Amer., 24: 323, 1997.
9. Bazinet, M., Meshref, A. W., Trudel, C., Aronson, S., Péloquin, F., Nachabe, M., Bégin, L. R. and Elhilali, M. M.: Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology, 43: 44, 1994.
10. Carter, H. B. and Pearson, J. D.: Prostate-specific antigen velocity and repeated measures of prostate-specific antigen. Urol. Clin. N. Amer., 24: 333, 1997.
11. Richardson, T. D. and Oesterling, J. E.: Age-specific reference ranges for serum prostate-specific antigen. Urol. Clin. N. Amer., 24: 339, 1997.
12. Kalish, J., Cooner, W. H. and Graham, S. D., Jr.: Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology, 43: 601, 1994.
13. Kurita, Y., Ushiyama, T., Suzuki, K., Fujita, K. and Kawabe, K.: PSA value adjusted for the transition zone volume in the diagnosis of prostate cancer. Int. J. Urol., 3: 367, 1996.
14. Zlotta, A. R., Djavan, B., Marberger, M. and Schulman, C. C.: Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J. Urol., 157: 1315, 1997.
15. Hammerer, P. G., Mc Neal, J. E. and Stamey, T. A.: Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J. Urol., 153: 111, 1995.
16. Lepor, H., Wang, B. and Shapiro, E.: Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology, 44: 199, 1994.
17. Morgan, T. O., Jacobsen, S. J., McCarthy, W. F., Jacobson, D. J., McLeod, D. G. and Moul, J. W.: Age-specific reference ranges for prostate-specific antigen in black men. New Engl. J. Med., 335: 304, 1996.
18. Creasy, T., Lesna, M., Rundle, D., Bramble, J. and Morley, R.: Central gland PSA density - a more sensitive tool for the diagnosis of carcinoma of the prostate. J. Urol., part 2, 157: 55, abstract 209, 1997.
19. Partin, A. W. and Oesterling, J. E.: The clinical usefulness of prostate specific antigen: update 1994. J. Urol., 152: 1358, 1994.
20. Horninger, W., Reissigl, A., Klockler, H., Höltl, L., Fink, K. and Bartsch, G.: Improvement of early detection of prostate cancer by using PSA-transitional zone density (PSA-TZ density) and percent free PSA in addition to total PSA levels. J. Urol., part 2, 157: 116, abstract 454, 1997.
21. Maeda, H., Ishitoya, S., Maekawa, Y., Aoki, Y., Okubo, K., Okada, T., Suzuki, Y. and Arai, Y.: Prostate specific antigen density of the transition zone in the detection of prostate cancer. J. Urol., part 2, 157: 58, abstract 219, 1997.
22. Gohji, K., Nomi, M., Egawa, S., Morisue, K., Takenaka, A., Okamoto, M., Ohori, M. and Fuj, A.: Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Cancer, 79: 1969, 1970.
23. Catalona, W. J., Richie, J. P., deKernion, J. B., Ahmann, F. R., Ratliff, T. L., Dalkin, B. L., Kavoussi, L. R., MacFarlane, M. T. and Southwick, P. C.: Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J. Urol., 152: 2031, 1994.
24. Zlotta, A. R., Djavan, B., Roumeguère, T., Marberger, M. and Schulman, C. C.: Transition zone volume on transrectal ultrasonography is more accurate and reproducible than the total prostate volume. Brit. J. Urol., suppl., 80: A 926, 1997.
25. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Patel, A., Flanigan, R. C., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Herschman, J. D., Subong, E. N. P., Petteway, J. C., Parson, R. E., Loveland, K. G., Gasior, G. H. and Southwick, P. C.: A multicenter clinical trial evaluation of free PSA in the differentiation of prostate cancer from benign disease. J. Urol., part 2, 157: 111, abstract 434, 1997.
26. Chen, Y. T., Luderer, A. A., Thiel, R. P., Carlson, G., Cuny, C. L. and Soriano, T. F.: Using proportions of free to total prostate-specific antigen, age and total prostate-specific antigen to predict the probability of prostate cancer. Urology, 47: 518, 1996.
27. Stephan, C., Lein, M., Jung, K., Schnorr, D. and Loening, S. A.: The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer, 79: 104, 1997.
28. Roehrborn, C. G., Gregory, A., McConnell, J. D., Sagalowsky, A. I. and Wians, F. H., Jr.: Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology. Urology, suppl., 48: 23, 1996.
29. Prestigiacomo, A. F., Lilja, H., Pettersson, K., Wolfert, R. L. and Stamey, T. A.: A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario. J. Urol., 156: 350, 1996.
30. Partin, A. W., Catalona, W. J., Southwick, P. C., Subong, E. N., Gasior, G. H. and Chan, D. W.: Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology, suppl., 48: 55, 1996.